Vaccine Contract Manufacturing Market Size, Share, Demand, Comapnies and Forecast 2023-2028

IMARC Group has recently released a new research study titled "Vaccine Contract Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.

How big is the vaccine contract manufacturing market?

The global vaccine contract manufacturing market reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2028, exhibiting a growth rate (CAGR) of 10.8% during 2023-2028.

Vaccine contract manufacturing refers to the process of outsourcing the production of vaccines to a third-party manufacturer. This allows pharmaceutical companies to leverage the expertise and infrastructure of specialized contract manufacturers to produce their vaccines at wide scale. Vaccine contract manufacturing involves a complex and highly regulated process, requiring adherence to strict quality standards and regulatory guidelines. Contract manufacturers are responsible for the production of the vaccine, including sourcing raw materials, formulation, filling, and packaging. They may also provide additional services, such as clinical trials, product testing, and regulatory compliance support. The use of contract manufacturing can increase efficiency, reduce costs, and accelerate vaccine development and distribution.

Request to Get the Sample Report: https://www.imarcgroup.com/vaccine-contract-manufacturing-market/requestsample

Vaccine Contract Manufacturing Market Trends and Growth Drivers: 

The increased demand for vaccines represents a key factor driving the market growth across the globe. This is also supported by the COVID-19 pandemic which has highlighted the importance of vaccines, thus leading to a significant rise in the demand for vaccines globally. In line with this, the rising focus of contract manufacturers to reduce costs associated with manufacturing, quality control, and regulatory compliance as well as bridge the capacity gap and enable companies to scale up production quickly are contributing to the growth of the market. Apart from this, advances in vaccine technology, along with the development of more complex vaccines that require specialized expertise and infrastructure are creating a positive outlook for the market.

Leading Companies Operating in the Vaccine Contract Manufacturing Market:

• Ajinomoto Co. Inc.
• Albany Molecular Research Inc
• Catalent Inc
• Cobra Biologics Limited (Charles River Laboratories International Inc.)
• Cytovance Biologics Inc. (Hepalink USA Inc.)
• Fujifilm Holdings Corporation
• ICON plc
• Lonza Group AG
• Merck KGaA
• Pharmaceutical Product Development LLC
• PRA Health Sciences Inc.

Vaccine Contract Manufacturing Market Report Segmentation:

Breakup by Vaccine Type:

• Attenuated
• Inactivated
• Subunit-based
• Toxoid-based
• DNA-based

Breakup by Workflow:

• Downstream
• Fill and Finish Operations
• Analytical and QC Studies
• Packaging
• Upstream
• Mammalian Expression Systems
• Bacterial Expression Systems
• Yeast Expression Systems
• Baculovirus/Insect Expression Systems
• Others

Breakup by Application:

• Human Use
• Veterinary

Regional Insights:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=3872&flag=C

Key Highlights of the Report:

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.